SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001213900-21-031137
Filing Date
2021-06-07
Accepted
2021-06-07 07:06:06
Documents
1
Group Members
ALAN CUNNINGHAMCHRIS DUNKDEANE RHODESEMPOWER INSURANCE CORP LTD.GEORGE SASKOGLOBAL REVERB CORPJAMES NORMAN CURLEYJOEL YANOWITZPAUL PUSKADIRASTER INVESTMENTS, INC.ROBERT J. DAILEYROGER D. BOZARTHROGOFF FAMILY TRUST DTD 5/10/1999

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ea142184-13dgriffin_immune.htm SC 13D 383595
  Complete submission text file 0001213900-21-031137.txt   385406
Mailing Address 2431 ALOMA AVE #124 WINTER PARK FL 32792
Business Address 2431 ALOMA AVE #124 WINTER PARK FL 32792 (888) 613-8802
Immune Therapeutics, Inc. (Subject) CIK: 0001559356 (see all company filings)

IRS No.: 593226705 | State of Incorp.: FL | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88438 | Film No.: 21998200
SIC: 2834 Pharmaceutical Preparations

Mailing Address 37 NORTH ORANGE AVENUE, SUITE 607 ORLANDO FL 32801
Business Address 888 613 8802
Griffin Noreen (Filed by) CIK: 0001611517 (see all company filings)

Type: SC 13D